Silberberg DH. Azathioprine in multiple sclerosis: the cons. Neurology 1988; 38(suppl 2): 24-26. Hauser SL, Dawson DM, Lehrich Jr, et al. Intensive immunosuppression in progress multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange and ACTH.
St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. British journal of clinical pharmacology. 2002; 54(4):349-356. 5. Ashkenazi A, Silberstein S. Menstrual migraine: a review of hormonal causes, prophylaxis and treatment.
Mol Microbiol 1998;30: 819-30 (21) Reynolds PE, Courvalin P. Vancomycin resistance by synthesis of precursors terminating in D-alanyl-D-alanine. Antimicrob Agents Chemother 2005;49:21-5. (22) Depardieu F, Reynolds PE, Courvalin P. VanD-type vancomycin-resistantEnterococcus faecium 10/96A. Antimicrob Agents Chemother 2003;47:7-18.
1 Inflammation in multiple sclerosis: the good, the bad, and the complex47, S232–S240. Martino, G., Furlan, R. & Poliani, P. L. The pathogenic role of inflammation in multiple sclerosis. Rev Neurol. 2000 Jun 16-30; 30(12):1213-7. Rooks, A.
Banerji U, O'Donnell A, Scurr M, et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J Clin Oncol 2005; 23: 4152–61. 15. Neckers L, Neckers K. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents.
Drug Development Research, 68, 428-431. Verdu, B., Decosterd, I., Buclin, T., & Stiefel, F. (2008). Antidepressants for the treatment of chronic pain. Drugs, 68 (18), 2611-2632. Wall, P. D., & Melzack, R. (2008).
Petro, D.J., Ellenberger, C.E. Journal of Clinical Pharmacology, "Treatment of Human Spasticity with Delta-9-Tetrahydrocannabinol." 1981; 21: 413S-416S. Sibley, William A. (1996).
Malignant Hyperthermia is triggered by anesthetics, which includes common inhalants, and by medication containing succinylcholine, a substance often used as a muscle relaxant in emergency medicines.  After the initial ... ... middle of paper ... ...anodine receptor-Ca2+ release channels in malignant hyperthermia." Biophys J. 73(4) Oct 1997 29. Jul 2008 .